doi: 10.1038/s41583-021-00536-7
BPC-157 is a synthetic 15-amino-acid peptide derived from a naturally occurring gastric-juice protein, prized in laboratory models for its potent tissue repair and angiogenic signaling
Breast implants are designed to be life-long medical devices
Purchasing and using unlicensed peptides carries substantial risks, including unknown purity, incorrect dosing, and the absence of medical supervision
Comment: A few commenters asked for CMS to add HCPCS code Q2056 (Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose) to this list of Cell and Gene Therapies excluded from C-APC packaging for CY 2026
Split up reconstituted peptide into small amounts to avoid freeze-thaw cycles